Third Arc Bio

About:

Third Arc Bio is a biotech company developing multifunctional antibodies for inflammatory and immunology diseases.

Website: https://thirdarcbio.com

Top Investors: AbbVie, Cormorant Asset Management, Abrdn, Marshall Wace, Foresite Capital

Description:

Third Arc Bio is a biotech company developing multifunctional antibodies for inflammatory and immunology diseases. Its drug development engine delivers superior biologics optimized to create T-cell engagement by leveraging two technologies that power a pipeline of high-value therapeutics – a solid tumor synergy platform and an I&I platform that offers a novel approach to precision immune regulation at a tissue-specific level to achieve superior efficacy and safety.

Total Funding Amount:

$165M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2022-01-01

Founders:

Sanjaya Singh

Number of Employees:

1-10

Last Funding Date:

2024-07-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai